Latest Period
Q1 2026
Security Snapshot
LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock (LFCR) Institutional Ownership
CUSIP: 514766104
13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026
Institutions Reporting
104
Shares (Excl. Options)
25,113,769
Price
$3.72
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- LFCR on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 25,113,769
- Total 13F value
- $93,425,660
- Portfolio coverage rank
- 0%
- Share change
- +289,190
- Value change
- -$551,212
- Number of holders
- 104
- Shares outstanding
- 37,508,353
- SEC-reported price per share
- $4.94
- Insider filing price
- $4.94
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- LFCR - LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock is tracked under CUSIP 514766104.
- 104 institutions reported positions in Q1 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 102 to 104 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $202,785,326 to $93,425,660.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 104 institutions filings for Q1 2026.
Security key
514766104
Latest holder period
Q1 2026
13F holders
104
13D/G owners
4
CIK / CUSIP context first
Open Q1 2026 holders
LFCR full holder history
LIFECORE BIOMEDICAL, INC. \DE\ SEC filings
LIFECORE BIOMEDICAL, INC. \DE\ company facts
LIFECORE BIOMEDICAL, INC. \DE\ insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 514766104:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
LFCR
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Greenhaven Road Investment Management, L.P. | 9.8% | +25% | $22,998,689 | +$7,944,848 | 3,616,146 | +53% | Greenhaven Road Investment Management, L.P. | 31 Dec 2024 |
| 22NW Fund, LP | 7.5% | -33% | $20,768,278 | -$9,716,865 | 2,975,398 | -32% | 22NW Fund, LP | 27 May 2025 |
| BlackRock, Inc. | 5% | -2.4% | $6,949,021 | -$118,998 | 1,867,916 | -1.7% | BlackRock, Inc. | 31 Mar 2026 |
| David Capital Partners, LLC | 4.9% | $11,467,080 | 1,803,000 | David Capital Partners, LLC | 31 Dec 2024 |
As of 31 Mar 2026, 104 institutional investors reported holding 25,113,769 shares of LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock (LFCR). This represents 67% of the company’s total 37,508,353 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
64%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| WYNNEFIELD CAPITAL INC | 13% | 4,703,216 | 0% | 12% | $17,495,964 |
| Legion Partners Asset Management, LLC | 12% | 4,461,823 | 0% | 12% | $16,597,982 |
| Greenhaven Road Investment Management, L.P. | 9.4% | 3,537,573 | -3.9% | 9.1% | $13,159,772 |
| 325 CAPITAL LLC | 5.8% | 2,162,466 | 0% | 2.9% | $8,044,374 |
| BlackRock, Inc. | 5% | 1,877,305 | -1.6% | 0% | $6,983,574 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.4% | 1,290,136 | 0% | 0% | $4,799,306 |
| GRIZZLYROCK CAPITAL, LLC | 2.2% | 827,488 | +11% | 2.4% | $3,078,255 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.2% | 815,107 | +4.5% | 0% | $3,033,000 |
| MORGAN STANLEY | 2% | 764,734 | +1.8% | 0% | $2,844,812 |
| STATE STREET CORP | 1.7% | 642,006 | +9.7% | 0% | $2,388,262 |
| Quinn Opportunity Partners LLC | 1.2% | 453,495 | +87% | 0.09% | $1,687,001 |
| DCF Advisers, LLC | 1.1% | 424,500 | -4% | 0.6% | $1,579,140 |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 0.8% | 301,815 | +1289% | 0.42% | $1,122,752 |
| VANGUARD FIDUCIARY TRUST CO | 0.63% | 237,065 | 0% | 0% | $881,882 |
| NORTHERN TRUST CORP | 0.61% | 228,158 | +1.4% | 0% | $848,748 |
| LPL Financial LLC | 0.55% | 207,790 | +84% | 0% | $772,979 |
| GOLDMAN SACHS GROUP INC | 0.45% | 168,376 | +80% | 0% | $626,359 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.44% | 164,560 | 0% | 0% | $612,163 |
| MILLENNIUM MANAGEMENT LLC | 0.42% | 157,157 | -38% | 0% | $584,624 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 0.4% | 151,700 | 0% | 0.01% | $564,324 |
| GSA CAPITAL PARTNERS LLP | 0.34% | 125,750 | +52% | 0.03% | $468,000 |
| Diametric Capital, LP | 0.28% | 105,149 | -11% | 0.1% | $391,154 |
| GAMCO INVESTORS, INC. ET AL | 0.22% | 83,800 | 0% | 0% | $311,736 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.21% | 79,978 | -8.8% | 0% | $297,518 |
| Qube Research & Technologies Ltd | 0.2% | 75,097 | 0% | $279,361 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 25,113,769 | $93,425,660 | -$551,212 | $3.72 | 104 |
| 2025 Q4 | 24,790,192 | $202,785,326 | +$3,377,781 | $8.18 | 102 |
| 2025 Q3 | 24,334,820 | $179,104,999 | -$442,653 | $7.36 | 99 |
| 2025 Q2 | 24,384,958 | $198,008,217 | +$13,339,387 | $8.12 | 84 |
| 2025 Q1 | 22,755,067 | $160,201,265 | -$2,326,304 | $7.04 | 85 |
| 2024 Q4 | 23,042,098 | $171,205,266 | +$31,378,307 | $7.43 | 74 |
| 2024 Q3 | 18,933,619 | $93,344,132 | +$959,877 | $4.93 | 80 |
| 2024 Q2 | 18,597,383 | $95,407,619 | -$6,051,109 | $5.13 | 73 |
| 2024 Q1 | 21,527,122 | $114,309,004 | +$1,281,084 | $5.31 | 75 |
| 2023 Q4 | 21,214,493 | $131,315,483 | +$7,746,225 | $6.19 | 77 |
| 2023 Q3 | 17,649,982 | $132,309,917 | -$4,239,641 | $7.54 | 67 |
| 2023 Q2 | 17,960,139 | $173,672,855 | -$23,585,436 | $9.67 | 73 |
| 2023 Q1 | 21,626,729 | $81,665,566 | -$19,155,973 | $3.78 | 79 |
| 2022 Q4 | 24,699,229 | $160,060,929 | -$420,882 | $6.48 | 92 |
| 2022 Q3 | 24,756,452 | $220,096,095 | -$5,076,219 | $8.89 | 84 |
| 2022 Q2 | 25,281,897 | $252,055,903 | -$4,813,620 | $9.97 | 86 |
| 2022 Q1 | 23,496,502 | $272,006,071 | -$4,453,715 | $11.58 | 94 |
| 2021 Q4 | 25,875,011 | $287,157,179 | +$3,096,368 | $11.10 | 95 |
| 2021 Q3 | 25,537,059 | $235,449,630 | +$11,336,792 | $9.22 | 91 |
| 2021 Q2 | 25,595,693 | $287,942,521 | -$5,835,307 | $11.25 | 95 |
| 2021 Q1 | 25,969,624 | $275,201,016 | -$6,203,031 | $10.60 | 92 |
| 2020 Q4 | 26,546,714 | $288,027,507 | -$1,865,390 | $10.85 | 95 |
| 2020 Q3 | 27,293,895 | $265,303,644 | +$8,398,552 | $9.72 | 95 |
| 2020 Q2 | 26,759,176 | $213,024,082 | -$2,393,394 | $7.96 | 91 |
| 2020 Q1 | 27,069,384 | $235,223,542 | -$2,453,651 | $8.69 | 87 |